Mei-Sze Chua

Publications

• NIR-II Imaging of Hepatocellular Carcinoma Based on a Humanized Anti-GPC3 Antibody
  RSC Medicinal Chemistry. Jan, 2022  |   Pubmed ID: 35224499
• Analysis of Infected Host Gene Expression Reveals Repurposed Drug Candidates and Time-Dependent Host Response Dynamics for COVID-19
  BioRxiv : the Preprint Server for Biology. Jun, 2020  |   Pubmed ID: 32511305
• An NIR-II/MR Dual Modal Nanoprobe for Liver Cancer Imaging
  Nanoscale. Jun, 2020  |   Pubmed ID: 32428058
• High Inflammatory Factor Grading Predicts Poor Disease-Free Survival in AJCC Stage I-II Hepatocellular Carcinoma Patients After R0 Resection
  Cancer Management and Research. 2019  |   Pubmed ID: 31908534
• An Automated, Quantitative, and Multiplexed Assay Suitable for Point-of-Care Hepatitis B Virus Diagnostics
  Scientific Reports. 10, 2019  |   Pubmed ID: 31666635
• Correction: SOCS5 Inhibition Induces Autophagy to Impair Metastasis in Hepatocellular Carcinoma Cells Via the PI3K/Akt/mTOR Pathway
  Cell Death & Disease. Oct, 2019  |   Pubmed ID: 31641102
• SOCS5 Inhibition Induces Autophagy to Impair Metastasis in Hepatocellular Carcinoma Cells Via the PI3K/Akt/mTOR Pathway
  Cell Death & Disease. 08, 2019  |   Pubmed ID: 31406106
• A Transfer-RNA-derived Small RNA Regulates Ribosome Biogenesis
  Nature. 12, 2017  |   Pubmed ID: 29186115
• 5-Hydroxymethylcytosine Signatures in Cell-free DNA Provide Information About Tumor Types and Stages
  Cell Research. Oct, 2017  |   Pubmed ID: 28820176
• Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling
  Gastroenterology. 06, 2017  |   Pubmed ID: 28284560
• Suppression of ATAD2 Inhibits Hepatocellular Carcinoma Progression Through Activation of P53- and P38-mediated Apoptotic Signaling
  Oncotarget. Dec, 2015  |   Pubmed ID: 26497681
• NDRG1 Promotes Growth of Hepatocellular Carcinoma Cells by Directly Interacting with GSK-3β and Nur77 to Prevent β-catenin Degradation
  Oncotarget. Oct, 2015  |   Pubmed ID: 26359353
• Tankyrase Inhibitors Attenuate WNT/β-catenin Signaling and Inhibit Growth of Hepatocellular Carcinoma Cells
  Oncotarget. Sep, 2015  |   Pubmed ID: 26246473
• Novel Celastrol Derivatives Inhibit the Growth of Hepatocellular Carcinoma Patient-derived Xenografts
  Oncotarget. Jul, 2014  |   Pubmed ID: 25051375
• Imaging of Hepatocellular Carcinoma Patient-derived Xenografts Using ⁸⁹Zr-labeled Anti-glypican-3 Monoclonal Antibody
  Biomaterials. Aug, 2014  |   Pubmed ID: 24836949
• Epigenetics in Hepatocellular Carcinoma: an Update and Future Therapy Perspectives
  World Journal of Gastroenterology. Jan, 2014  |   Pubmed ID: 24574704
• Suppressing N-Myc Downstream Regulated Gene 1 Reactivates Senescence Signaling and Inhibits Tumor Growth in Hepatocellular Carcinoma
  Carcinogenesis. Apr, 2014  |   Pubmed ID: 24302615
• Molecular Imaging of Hepatocellular Carcinoma Xenografts with Epidermal Growth Factor Receptor Targeted Affibody Probes
  BioMed Research International. 2013  |   Pubmed ID: 23710458
• Assessment and Comparison of Magnetic Nanoparticles As MRI Contrast Agents in a Rodent Model of Human Hepatocellular Carcinoma
  Contrast Media & Molecular Imaging. Jul-Aug, 2012  |   Pubmed ID: 22649042
• Suppression of Glypican 3 Inhibits Growth of Hepatocellular Carcinoma Cells Through Up-regulation of TGF-β2
  Neoplasia (New York, N.Y.). Aug, 2011  |   Pubmed ID: 21847365
• Soluble Frizzled-7 Receptor Inhibits Wnt Signaling and Sensitizes Hepatocellular Carcinoma Cells Towards Doxorubicin
  Molecular Cancer. Feb, 2011  |   Pubmed ID: 21314951
• Rodent-specific Hypoxia Response Elements Enhance PAI-1 Expression Through HIF-1 or HIF-2 in Mouse Hepatoma Cells
  International Journal of Oncology. Dec, 2010  |   Pubmed ID: 21042733
• Small Molecule Antagonists of Tcf4/beta-catenin Complex Inhibit the Growth of HCC Cells in Vitro and in Vivo
  International Journal of Cancer. May, 2010  |   Pubmed ID: 19662654
• Blockade of Wnt-1 Signaling Leads to Anti-tumor Effects in Hepatocellular Carcinoma Cells
  Molecular Cancer. Sep, 2009  |   Pubmed ID: 19778454
• Antibody Arrays Identify Potential Diagnostic Markers of Hepatocellular Carcinoma
  Biomarker Insights. Jan, 2008  |   Pubmed ID: 19578489
• Small Interfering RNA Targeting CDC25B Inhibits Liver Tumor Growth in Vitro and in Vivo
  Molecular Cancer. Feb, 2008  |   Pubmed ID: 18269767
• N-Myc Down-regulated Gene 1 Mediates Proliferation, Invasion, and Apoptosis of Hepatocellular Carcinoma Cells
  Cancer Letters. Apr, 2008  |   Pubmed ID: 18207320
• Overexpression of NDRG1 is an Indicator of Poor Prognosis in Hepatocellular Carcinoma
  Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc. Jan, 2007  |   Pubmed ID: 17170744
• Gallium Maltolate is a Promising Chemotherapeutic Agent for the Treatment of Hepatocellular Carcinoma
  Anticancer Research. May-Jun, 2006  |   Pubmed ID: 16827101
• Applications of Microarrays to Renal Transplantation: Progress and Possibilities
  Frontiers in Bioscience : a Journal and Virtual Library. Sep, 2003  |   Pubmed ID: 12957854
• Microarrays: New Tools for Transplantation Research
  Pediatric Nephrology (Berlin, Germany). Apr, 2003  |   Pubmed ID: 12700956
• Increased Expression of Cytotoxic Effector Molecules: Different Interpretations for Steroid-based and Steroid-free Immunosuppression
  Pediatric Transplantation. Feb, 2003  |   Pubmed ID: 12581329
• Molecular Profiling of Anemia in Acute Renal Allograft Rejection Using DNA Microarrays
  American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. Jan, 2003  |   Pubmed ID: 12492705